- Research works
- 97 ▲ 24% vs 2013–17
- Citations
- 1.8k 18.5 per fractional work
- Top-10% rate
- 11.9% record average 16.5%
- Open access
- 49% world 28%
Not ranked overall: Veracyte (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Veracyte (United States) specialise in?
Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.
- MedicineField · 30.1 works3.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.8×. Every wedge is a field page.
Who are the top researchers at Veracyte (United States)?
Ranked on the composite score, Giulia C. Kennedy and Yangyang Hao lead among researchers whose main affiliation is Veracyte (United States).
- 1 Giulia C. Kennedy United States · #252,962 worldwide 146 citations · 19 works
- 2 Yangyang Hao United States · #1,568,532 worldwide 10 citations · 20 works
Which keywords describe research at Veracyte (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Prostate Cancer, Immunotherapy, Clinical Trials, Genomic Profiling, Genetic Mutations, Biomarkers, Hormone Therapy and Androgen Receptor.
- EGFR Mutations
- Breast Cancer
- Genetic Testing
- Cancer Risk
- Neoadjuvant Therapy
- Radiotherapy
- Radiomics
- Molecular Characterization
- Quantitative Analysis
- Screening
- Gleason Grading
- Genetic Variants
- Targeted Therapy
- Precision Medicine
- Differentiated Thyroid Cancer
- BRAF Mutation
- Androgen Receptor
- Genetic Mutations
- Genomic Profiling
- Immunotherapy
- Prostate Cancer
- Clinical Trials
- Biomarkers
- Hormone Therapy
- Metastatic Prostate Cancer
- Thyroid Carcinoma
- Thyroid Nodules
- Clinical Guidelines
- Chemotherapy
- Machine Learning
- Radiation Therapy
- Cancer
- Medical Imaging
- Feature Extraction
- Tumor Microenvironment
- Genomic Instability
- Cancer Genomics
- Gene Expression
- Mutational Signatures
- ALK Inhibitors
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Prostate Cancer11▲ 195×3 topics
- Immunotherapy10▲ 32×8 topics
- Clinical Trials9▲ 32×3 topics
- Genomic Profiling9▲ 202×2 topics
- Biomarkers8▲ 27×4 topics
- Genetic Mutations8▲ 43×2 topics
- Hormone Therapy7▲ 218×2 topics
- Androgen Receptor7▲ 239×1 topic
- Metastatic Prostate Cancer7▲ 431×1 topic
- BRAF Mutation5▲ 158×2 topics
- Thyroid Carcinoma5▲ 226×2 topics
- Differentiated Thyroid Cancer4▲ 270×1 topic
- Thyroid Nodules4▲ 270×1 topic
- Precision Medicine4▲ 20×5 topics
- Clinical Guidelines4▲ 31×3 topics
- Targeted Therapy4▲ 39×4 topics
- Chemotherapy3▲ 11×8 topics
- Genetic Variants3▲ 46×3 topics
- Machine Learning3▲ 2.4×5 topics
- Gleason Grading3▲ 195×1 topic
- Radiation Therapy3▲ 59×1 topic
- Screening3▲ 83×2 topics
- Cancer3▲ 5.2×13 topics
- Quantitative Analysis2▲ 28×2 topics
- Medical Imaging2▲ 10×2 topics
- Molecular Characterization2▲ 30×3 topics
- Feature Extraction2▲ 11×1 topic
- Radiomics2▲ 42×1 topic
- Tumor Microenvironment2▲ 11×6 topics
- Radiotherapy2▲ 12×5 topics
- Genomic Instability2▲ 39×3 topics
- Neoadjuvant Therapy2▲ 18×4 topics
- Cancer Genomics2▲ 58×1 topic
- Cancer Risk2▲ 19×3 topics
- Gene Expression2▲ 6.9×6 topics
- Genetic Testing2▲ 36×2 topics
- Mutational Signatures2▲ 58×1 topic
- Breast Cancer2▲ 16×4 topics
- ALK Inhibitors1▲ 53×1 topic
- EGFR Mutations1▲ 53×1 topic
Which research topics does Veracyte (United States) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Thyroid Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 7 works
- 2 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 4 works
- 3 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 5 Cancer Genomics and Diagnostics Cancer Research 2 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 8 BRCA gene mutations in cancer Genetics 1 works
- 9 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Veracyte (United States)'s research output changed?
Output in 2018–2022 was 24% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South San Francisco
- Sunesis (United States)
- Exelixis (United States)
- Kaiser Permanente South San Francisco Medical Center
- Cytokinetics (United States)
- Portola Pharmaceuticals (United States)
- NGM Biopharmaceuticals (United States)
- Rapt Therapeutics (United States)
- Atara Biotherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.